Cuprymina (copper (64Cu) chloride)
- Region
- 🇪🇺 EU
- Active substance
- copper (64Cu) chloride
- Company
- A.C.O.M. - Advanced Center Oncology
- Status
- Authorised
- Therapeutic area
- Radionuclide Imaging
- EU approval
- Thu 23 Aug 2012
- Application
- EMEA/H/C/002136
- ATC
- Not yet assigned
- Official record
- www.ema.europa.eu
Indication
Cuprymina is a radiopharmaceutical precursor. It is not intended for direct use in patients. This medicinal product must be used only for the radiolabelling of carrier molecules, which have been specifically developed and authorised for radiolabelling with this radionuclide.
Regulatory milestones
No milestones recorded in the last year.
Follow Cuprymina
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.